The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
about
Lipoprotein genotype and conserved pathway for exceptional longevity in humansGenetic predisposition to cancer — insights from population geneticsFrequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patientsLocalization of BRCA1 protein in breast cancer tissue and cell lines with mutationsAverage risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesGeographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selectionFounder mutations in the BRCA1 gene in Polish families with breast-ovarian cancerFounder populations and their uses for breast cancer genetics.Recommendations on screening for breast cancer in average-risk women aged 40-74 yearsVariation of breast cancer risk among BRCA1/2 carriers.BRCA1 inhibition of telomerase activity in cultured cellsGynaecomastia and breast cancer in menEvidence of a founder BRCA1 mutation in ScotlandBRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cellsMeta-analysis of BRCA1 and BRCA2 penetranceBRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarianAshkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic diseaseIncreased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell lineFounder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancerCancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation statusLog odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers.Community involvement in the ethical review of genetic research: lessons from American Indian and Alaska Native populationsBRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolutionGenetic Misdiagnoses and the Potential for Health DisparitiesNew challenges for BRCA testing: a view from the diagnostic laboratoryOvarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionMediterranean diet for breast cancer prevention and treatment in postmenopausal womenOncological safety of prophylactic breast surgery: skin-sparing and nipple-sparing versus total mastectomyInherited pancreatic cancer syndromesRedefining the impact of nutrition on breast cancer incidence: is epigenetics involved?Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and reviewBias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation CarriersRole of direct interaction in BRCA1 inhibition of estrogen receptor activityDirect interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cellsAdenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cellsDisruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein bindingThe National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial
P2860
Q21146060-4AEA5985-E618-446B-A6D5-B5142A8F30B1Q22122022-3E775030-396A-40C4-8BD9-96AF8D2BEC96Q24170410-4CB112DE-9FD5-475E-B232-83B27DF7D3B2Q24308016-DAE4109E-4907-4759-A031-27161ADC0BFAQ24531993-5245FCEE-1D13-491A-AE24-C713798E79BFQ24532103-F40A0455-5F2D-4B3D-8299-BA05C0E489F6Q24540270-BC475F73-A5E3-4590-8C07-1FEA99B4DAF8Q24544179-100AB225-049A-4F79-AC6B-59CEB31D511DQ24633913-49872AD4-168D-413D-B5B8-48488D0DA414Q24646346-F63D9AFF-7C45-44EE-9E79-59A620AD64DAQ24648491-5B7A2950-152A-47C8-821E-B26B173B116BQ24648830-AB8ABDAC-9517-4A29-B4B6-6E037EF72EA1Q24649433-63FFDA3B-53EA-40DC-B800-16D9B063E81FQ24652441-B02422E2-1E9F-4B6E-8871-7695717906BEQ24654786-8F14D8AE-6FCC-4E07-AE55-934C62A1C254Q24672251-5184C42D-886B-4D11-BFA0-ED4136CDF37EQ24675652-BF854DFE-8C60-4414-8C91-115699477E26Q24791221-F6ADA473-A79B-4DC5-8A04-343B6A661294Q24798248-D100949A-3082-4920-9470-2DD5177AD6F8Q24802534-97BD4670-FD83-4F04-8072-ADA7CFFF33A8Q24802704-5AA9659E-116D-4E0F-84C0-394DC2C65E00Q24803349-B8ED96AD-E631-4024-B444-BB0290451B1FQ24811808-7C705657-B377-4F9C-975A-32A18A127CBDQ25255829-3FE7748D-9E6A-4080-9CE2-373E9704B908Q26316693-AC9538C9-8ED1-409C-9FBE-77F3876FFB71Q26741855-D9B3E493-80B2-42DA-846A-A6C0F117510EQ26744525-9370E76A-F651-4BB2-B86B-C336C725788AQ26768711-43D38195-F14F-431D-B2C3-82DB303F1529Q26773609-35B7F487-9794-4599-B782-52A07CA4AE26Q26853530-4FB59B05-6872-4E99-A5E6-F468301AEBBDQ27011732-BEA734D6-8403-41CF-99D6-EB1F3C53D88FQ28066454-E8C8E461-61D6-4FFB-8B5D-7B0DBCC2DE0FQ28077192-A0C9872C-D965-455B-B7AC-50DAE59464B1Q28085448-E40370DA-5728-427F-B5CE-C1983415F8D7Q28204456-638869E3-1233-4EF7-8C43-26276C7821F3Q28210850-0410E733-DB8C-4F0D-815B-8654216C08CDQ28212223-4613B1C4-24FF-41EE-8D84-7AA183836638Q28213710-D85B083C-B2D3-4EB8-A1FD-F81149ACED6AQ28214375-4E06BCC0-CBD7-49E8-9334-E6F413FA2D07Q28217652-FE3FF84C-7299-434F-840C-1DC3E2D76A32
P2860
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
description
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1997
@ast
im Mai 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 15 May 1997)
@en
wetenschappelijk artikel (gepubliceerd op 1997/05/15)
@nl
наукова стаття, опублікована в травні 1997
@uk
مقالة علمية (نشرت في 15-5-1997)
@ar
name
The risk of cancer associated ...... and BRCA2 among Ashkenazi Jews
@ast
The risk of cancer associated ...... and BRCA2 among Ashkenazi Jews
@en
type
label
The risk of cancer associated ...... and BRCA2 among Ashkenazi Jews
@ast
The risk of cancer associated ...... and BRCA2 among Ashkenazi Jews
@en
prefLabel
The risk of cancer associated ...... and BRCA2 among Ashkenazi Jews
@ast
The risk of cancer associated ...... and BRCA2 among Ashkenazi Jews
@en
P2093
P3181
P1476
The risk of cancer associated ...... and BRCA2 among Ashkenazi Jews
@en
P2093
Struewing JP
Timmerman MM
P304
P3181
P356
10.1056/NEJM199705153362001
P407
P577
1997-05-15T00:00:00Z